This site provides INTERCEPT product information for International audiences Select your region
Eliminate Gamma Irradiation
The INTERCEPT™ Blood System has received CE Mark approval to replace gamma irradiation of platelet components for the prevention of transfusion-associated graft versus host disease (TA-GVHD).
The benefits for blood centres that implement the INTERCEPT Blood System include operational efficiencies and cost savings, thanks to the replacement of specific tests, procedures and production practices.